Psoriasis Clinical Trial
Dose Ranging Study To Assess Efficacy, Safety and Tolerability Of PF-06700841 Topical Cream In Psoriasis
Summary
This is a Phase 2b, randomized, double blind, vehicle controlled, parallel group, multicenter study in participants with mild to moderate plaque psoriasis. The duration of study participation will be approximately 22 weeks, including up to a 6 week screening period, 12 week treatment period, and approximately 4 week follow up period. Approximately 280 participants are planned to be randomized into the study.
Eligibility Criteria
Inclusion Criteria:
plaque psoriasis for 6 months
PGA score mild or moderate
body surface area (BSA) 2-15%
Exclusion Criteria:
other skin conditions that would interfere with the evaluation of psoriasis
history of herpes zoster or simplex
Infected with Mycobacterium tuberculosis
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 73 Locations for this study
Scottsdale Arizona, 85260, United States
Scottsdale Arizona, 85260, United States
Hot Springs Arkansas, 71913, United States
Anaheim California, 92801, United States
Anaheim California, 92801, United States
Encinitas California, 92024, United States
Fountain Valley California, 92708, United States
Santa Monica California, 90404, United States
Bridgeport Connecticut, 06606, United States
Shelton Connecticut, 06484, United States
Clearwater Florida, 33756, United States
DeLand Florida, 32720, United States
Jacksonville Florida, 32216, United States
Ocala Florida, 34470, United States
Ocala Florida, 34471, United States
Ocala Florida, 34471, United States
Orange Park Florida, 32073, United States
Tampa Florida, 33613, United States
West Dundee Illinois, 60118, United States
Clarksville Indiana, 47129, United States
Louisville Kentucky, 40241, United States
Baton Rouge Louisiana, 70808, United States
Saint Joseph Missouri, 64506, United States
Berlin New Jersey, 08009, United States
East Windsor New Jersey, 08520, United States
Bayside New York, 11360, United States
High Point North Carolina, 27262, United States
Raleigh North Carolina, 27612, United States
Tulsa Oklahoma, 74136, United States
Rapid City South Dakota, 57702, United States
Goodlettsville Tennessee, 37072, United States
Austin Texas, 78705, United States
Cypress Texas, 77433, United States
Houston Texas, 77004, United States
San Antonio Texas, 78218, United States
Webster Texas, 77598, United States
Franklin Virginia, 23851, United States
Norfolk Virginia, 23502, United States
Woolloongabba Queensland, 4102, Australia
Camberwell Victoria, 3124, Australia
East Melbourne Victoria, 3002, Australia
Malvern Victoria, 3144, Australia
Sofia , 1404, Bulgaria
Sofia , 1431, Bulgaria
Sofia , 1463, Bulgaria
Sofia , 1756, Bulgaria
Winnipeg Manitoba, R3M 3, Canada
Cobourg Ontario, K9A 4, Canada
Montreal Quebec, H2X 2, Canada
Sherbrooke Quebec, J1L 0, Canada
Hellerup , 2900, Denmark
Bad Bentheim , 48455, Germany
Berlin , 10629, Germany
Berlin , 10783, Germany
Berlin , 10789, Germany
Bielefeld , 33647, Germany
Dresden , 01307, Germany
Hamburg , 22391, Germany
Hamburg , 22391, Germany
Mahlow , 15831, Germany
Schwerin , 19055, Germany
Budapest , 1085, Hungary
Debrecen , 4032, Hungary
Kecskemet , 6000, Hungary
Szeged , 6720, Hungary
Sapporo-shi Hokkaido, 003-0, Japan
Kita-ku, Osaka-shi Osaka, 531-0, Japan
Minato-ku Tokyo, 106-0, Japan
Ota Ku Tokyo, 143-0, Japan
Shinjuku-ku Tokyo, 160-0, Japan
Tachikawa Tokyo, 190-0, Japan
Riga , LV-10, Latvia
Riga , LV-10, Latvia
Riga , LV-10, Latvia
Ventspils , LV360, Latvia
Bialystok , 15-35, Poland
Torun , 87-10, Poland
Warszawa , 02-10, Poland
Wroclaw , 51-68, Poland
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.